Advertisement

2018 Scientific Sessions Highlights

CRISPR-Cas9 genome editing for treatment of atherogenic dyslipidemia

Kiran Musunuru, MD, PhD, MPH

Kiran Musunuru, MD presents his talk on CRISPR-Cas9 genome editing for treatment of atherogenic dyslipidemia at the 2018 Scientific Sessions in Las Vegas, Nevada.

Start Presentation Slides Audio Only

Tags:


Update on Clinical Trials: How Will This Affect Practice in the Future?

Pamela B. Morris, MD, FACC, FAHA, FASPC, FNLA

Pamela Morris, MD presents her update on clinical trials at the 2018 Scientific Sessions in Las Vegas, Nevada.

Start Presentation Slides Audio Only

Tags:


Resistant Hypertension: A Practical Approach to the Guidelines

Michael J Bloch, MD, FACP, FASH, FSVM, FNLA

Michael Bloch, MD presents his talk on Resistant Hypertension at the 2018 Scientific Sessions in Las Vegas, Nevada.

Start Presentation Slides Audio Only

Tags:


Copyright © 2018 National Lipid Association. All Rights Reserved.

Privacy Policy Terms of Service